Exchange: NASDAQ·Updated 07:39 PM EDT
SLNO logo

SLNO Soleno Therapeutics Inc

$53.02
$0.02
(0.04%)
Today
Closed $53.01
$0.01
(0.02%)
After Hours
Reported EarningsMay 7
Mkt Cap$2.76B
Vol4.97M

About SLNO

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
72

Bullish Sentiment

How do you feel about SLNO?

Advertisement|Remove ads.